Penserra Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-87,000
| Closed | -$52K | – | 1340 |
|
|
2023
Q3 | $52K | Sell |
87,000
-12,352
| -12% | -$7.38K | ﹤0.01% | 991 |
|
|
2023
Q2 | $129K | Buy |
99,352
+61,642
| +163% | +$80K | ﹤0.01% | 898 |
|
|
2023
Q1 | $66K | Buy |
37,710
+2,090
| +6% | +$3.66K | ﹤0.01% | 821 |
|
|
2022
Q4 | $111K | Sell |
35,620
-8,257
| -19% | -$25.7K | ﹤0.01% | 792 |
|
|
2022
Q3 | $214K | Buy |
43,877
+31,829
| +264% | +$155K | 0.01% | 627 |
|
|
2022
Q2 | $49K | Buy |
12,048
+672
| +6% | +$2.73K | ﹤0.01% | 911 |
|
|
2022
Q1 | $66K | Buy |
+11,376
| New | +$66K | ﹤0.01% | 940 |
|
|
2021
Q4 | – | Sell |
-3,325
| Closed | -$29K | – | 1526 |
|
|
2021
Q3 | $29K | Buy |
3,325
+50
| +2% | +$436 | ﹤0.01% | 1191 |
|
|
2021
Q2 | $39K | Buy |
3,275
+20
| +0.6% | +$238 | ﹤0.01% | 1055 |
|
|
2021
Q1 | $40K | Sell |
3,255
-15
| -0.5% | -$184 | ﹤0.01% | 851 |
|
|
2020
Q4 | $51K | Buy |
3,270
+2,066
| +172% | +$32.2K | ﹤0.01% | 683 |
|
|
2020
Q3 | $11K | Buy |
+1,204
| New | +$11K | ﹤0.01% | 808 |
|